Autopsy report · NCT02257775

Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer

“Insufficient number of eligible and interested partients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 2 years 6 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Institute of Cancer Research, United Kingdom

Sponsor type

University, hospital or other

Conditions

Metastatic Breast Cancer

Interventions

n/a - observational

Participants

5

Sites

1

Countries

United Kingdom

Trials that died the same way

• Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia
  “lack of eligible participants” (66% match in meaning)
• Project 1: ACHIEVE- HTN
  “Due lack of eligible participants” (66% match in meaning)
• Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
  “Unable to recruit enough participants” (65% match in meaning)
• Long-term Benefit of Aortic Stent-graft in Patients With Distal Aortic Dissection
  “Not enough participants enrolled” (63% match in meaning)
• The Treatment of Recurrent Abdominal Pain in Children
  “Not enough interested participants” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.